CVE:NINE

Delta 9 Cannabis Stock Forecast, Price & News

C$1.03

+0.03 (+3.00 %)

(As of 07/23/2019)

Add

Compare

Today's Range

C$1.03

▼

C$1.13

50-Day Range

C$1.00

▼

C$1.03

52-Week Range

C$0.92

▼

C$2.35

Volume68,728 shs

Average Volume117,300 shs

Market CapitalizationC$89.36 million

P/E Ratio19.07

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive NINE News and Ratings via Email

Sign-up to receive the latest news and ratings for Delta 9 Cannabis and its competitors with MarketBeat's FREE daily newsletter.

About Delta 9 Cannabis

Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers. It also owns and operates retail cannabis store in Winnipeg, Manitoba, as well as cannabis superstore in Brandon, Manitoba. The company operates its retail stores under the Delta 9 Cannabis Store brand name. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.

Delta 9 Cannabis provides guidance for Q2 financials with what looks like a heavy rise in revenue
July 5, 2021 | proactiveinvestors.com

NA Proactive news snapshot: Delta 9 Cannabis, Plurilock Security, Amarillo Gold, Versus Systems, Los Andes Copper
June 23, 2021 | proactiveinvestors.com

Delta 9 Cannabis sees its 2Q revenue climbing as much as 33% to C$17.3M
June 23, 2021 | proactiveinvestors.com

Delta 9 Cannabis launches ‘Joints for Jabs’ vaccination reward program
June 21, 2021 | proactiveinvestors.com

NA Proactive news snapshot: Delta 9 Cannabis, North Arrow Minerals, Empower Clinics, NEO Battery Materials
June 21, 2021 | proactiveinvestors.com

Delta 9 Cannabis still sees growth in Q1 2021 financial numbers despite challenges
May 20, 2021 | proactiveinvestors.com

NA Proactive news snapshot: Delta 9 Cannabis, Acasti Pharma, XPhyto Therapeutics, Loop Insights
May 7, 2021 | proactiveinvestors.com

Delta 9 Cannabis expects 1Q revenue of C$12.9M to $13.3M on higher retail sales
May 7, 2021 | proactiveinvestors.com

Cultivation System that Enhances Opportunities in the Cannabis Industry—Delta 9
April 27, 2021 | msn.com

Delta 9 to Open Twelfth Cannabis Retail Store
April 14, 2021 | markets.businessinsider.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange CVE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:NINE
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.delta9.ca
Phone855-245-1259
Employees79
Year FoundedN/A

Sales & Book Value

Annual SalesC$12.87 million
Price / Sales6.94
Cash FlowC$0.09 per share
Price / Cash Flow11.91
Book ValueC$0.53 per share
Price / Book1.95

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares86,760,000
Market CapC$89.36 million
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

1.26 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Delta 9 Cannabis.

3.4 Community Rank

Outperform Votes
Delta 9 Cannabis has received 127 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Delta 9 Cannabis has received 60 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Delta 9 Cannabis has received 67.91% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Delta 9 Cannabis and other stocks. Vote “Outperform” if you believe NINE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NINE will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Delta 9 Cannabis does not currently pay a dividend.
Dividend Growth
Delta 9 Cannabis does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Delta 9 Cannabis insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$400.00 in company stock and sold C$0.00 in company stock.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Delta 9 Cannabis is 19.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.47.
Price to Earnings Ratio vs. Sector
The P/E ratio of Delta 9 Cannabis is 19.07, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 39.61.
Price to Book Value per Share Ratio
Delta 9 Cannabis has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Delta 9 Cannabis (CVE:NINE) Frequently Asked Questions

What stocks does MarketBeat like better than Delta 9 Cannabis?

Wall Street analysts have given Delta 9 Cannabis a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Delta 9 Cannabis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Delta 9 Cannabis' key executives?

Delta 9 Cannabis' management team includes the following people:

Mr. John William Arbuthnot III, Co-Founder, Pres & Chairman (Age 65)
Mr. John William Arbuthnot IV, Co-Founder, CEO & Director (Age 29)
Mr. Jim Lawson, Interim CFO & Controller
Mr. Matthew Sodomsky, Chief Technology Officer

Who are some of Delta 9 Cannabis' key competitors?

Some companies that are related to Delta 9 Cannabis include Amryt Pharma (AMYT), The Supreme Cannabis (FIRE), ESSA Pharma (EPI), Leaf Mobile (LEAF), ICC Labs (ICC), The Green Organic Dutchman (TGOD), Medexus Pharmaceuticals (MDP), Venture Life Group (VLG), Diurnal Group (DNL), Science in Sport (SIS), BioSyent (RX), Shield Therapeutics (STX), The Flowr (FLWR), WeedMD (WMD) and Acerus Pharmaceuticals (ASP).
View all of NINE's competitors.

What other stocks do shareholders of Delta 9 Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Delta 9 Cannabis investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Emerald Health Therapeutics (EMH), Allena Pharmaceuticals (ALNA), Bank of America (BAC), Auxly Cannabis Group (CBWTF), 298835 (GBU.TO) (GBU), Cannara Biotech (LOVE), TELUS (T) and SoFi Weekly Income ETF (TGIF).

What is Delta 9 Cannabis' stock symbol?

Delta 9 Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NINE."

How do I buy shares of Delta 9 Cannabis?

Shares of NINE and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Delta 9 Cannabis' stock price today?

One share of NINE stock can currently be purchased for approximately C$1.03.

How much money does Delta 9 Cannabis make?

Delta 9 Cannabis has a market capitalization of C$89.36 million and generates C$12.87 million in revenue each year.

How many employees does Delta 9 Cannabis have?

Delta 9 Cannabis employs 79 workers across the globe.

What is Delta 9 Cannabis' official website?

The official website for Delta 9 Cannabis is www.delta9.ca.

How can I contact Delta 9 Cannabis?

The company can be reached via phone at 855-245-1259.

This page was last updated on 7/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Delta 9 Cannabis Stock Forecast, Price & News

About Delta 9 Cannabis

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

3.4 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

1.7 Company Ownership

Insider Buying vs. Insider Selling

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio